Sign up
Quantellect · Congress · Congressional Trade

Thomas MacArthur bought Ionis Pharmaceuticals Inc (NASDAQ: IONS)

Thomas MacArthur bought Ionis Pharmaceuticals Inc (IONS), disclosed December 2, 2016

Thomas MacArthur bought IONS · disclosed December 2, 2016

Thomas MacArthur, a NJ House member representing District 3, purchased $1,001 - $15,000 of Ionis Pharmaceuticals Inc (IONS) on November 2, 2016. Filings associated with Thomas MacArthur disclosed 3 other IONS transactions (2 purchases and 1 sale) in the 12 months before this trade. Shares of IONS have fallen 25.6% since the first observed purchase on February 12, 2016. The filing was publicly disclosed on December 2, 2016; a direct filing link is not available in the current data record.

Follow this and other congressional disclosures on the Quantellect congress trading dashboard. For Thomas MacArthur's complete filing history, visit Thomas MacArthur's full trade history. Browse all trading members of Congress tracked by Quantellect.

Key points

  • Analyst ratings on IONS break down as 0 strong buy, 16 buy, 4 neutral, 0 sell, 0 strong sell.
  • IONS carries a Risk Score of 71 as of November 20, 2026. On this scale, a higher score means a lower risk surface.
  • Thomas MacArthur bought IONS in the amount range of $1,001 - $15,000 on November 2, 2016, filed under the STOCK Act.
  • The filing lists Dependent child as the transaction owner and was disclosed 30 days after the trade.
  • The asset description in the filing reads 'Ionis Pharmaceuticals, Inc. (IONS).'
  • Filings associated with Thomas MacArthur disclosed 3 other IONS transactions (2 purchases and 1 sale) in the 12 months before this trade.
  • Shares of IONS have fallen 25.6% since the first observed purchase on February 12, 2016.

Did Thomas MacArthur buy or sell IONS?

The Periodic Transaction Report covers a single purchase involving IONS on November 2, 2016. The filed amount range is $1,001 - $15,000. The asset description reads 'Ionis Pharmaceuticals, Inc. (IONS)', as submitted by the filer. The report was submitted on December 2, 2016. Under the STOCK Act, covered transactions generally must be reported within 30 days of receiving notice and no later than 45 days after the transaction.

PoliticianActionTickerAmountTrade dateFiled
Thomas MacArthur (House)BuyIONS$1,001 - $15,000November 2, 2016December 2, 2016

What other IONS trades has Thomas MacArthur disclosed in the past 12 months?

Filings associated with Thomas MacArthur disclosed 3 other IONS transactions (2 purchases and 1 sale) in the 12 months before this trade.

Trade dateActionOwnerAmountFiling
February 24, 2016BuyJoint$1,001 - $15,000Filing unavailable
February 12, 2016BuyJoint$1,001 - $15,000Filing unavailable
February 2, 2016SellJoint$15,001 - $50,000Filing unavailable

What does the filing show, and what does it not show?

The filing reports a purchase involving IONS by Thomas MacArthur in the amount range of $1,001 - $15,000, with Dependent child listed as the owner. It does not establish Thomas MacArthur's total holdings in IONS, any realized profit or loss, the reasons for the transaction, or any committee connection. The asset description reads 'Ionis Pharmaceuticals, Inc. (IONS)', as submitted by the filer; that label is reproduced without adding a legal or regulatory interpretation. Quantellect's current profile data does not identify Thomas MacArthur's committee assignments, so this article draws no connection between the trade and any legislative jurisdiction. Filings associated with Thomas MacArthur disclosed 3 other IONS transactions (2 purchases and 1 sale) in the 12 months before this trade. Quantellect tracks how disclosed purchases have performed, but does not treat corporate actions as buys or sells.

Who else in Congress traded IONS?

Quantellect's current database lists these recent IONS disclosures by other members. Owner labels come from the native filing row; an official filing link appears only when it is available in the source data.

MemberPartyActionAmountDisclosed
No recent disclosures by other members are available.

How has Thomas MacArthur's disclosed trading performed?

A current measured Member Score is not available for this member. Quantellect does not infer performance where the scored-trade projection lacks coverage.

All Thomas MacArthur IONS trades

TradedTypeSizeReturnEst. profit
November 2, 2016Buy$15,001 - $50,000-1.56%-$506
November 2, 2016Buy$1,001 - $15,000-1.56%-$124
November 2, 2016Buy$1,001 - $15,000-1.56%-$124
February 24, 2016Buy$1,001 - $15,000-24.34%-$2K
February 12, 2016Buy$1,001 - $15,000-25.63%-$2K
February 2, 2016Sell$15,001 - $50,000-25.36%—

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Frequently asked questions

Did Thomas MacArthur buy or sell IONS?

According to the disclosure, Thomas MacArthur purchased IONS on November 2, 2016.

What amount was reported for the IONS transaction?

The disclosure reports $1,001 - $15,000 for the purchase. Filed amounts are ranges, not exact transaction values.

When did the transaction occur, and when was it disclosed?

The transaction is dated November 2, 2016, and it was disclosed on December 2, 2016.

Where can I see Thomas MacArthur's other congressional trades?

Quantellect lists Thomas MacArthur's complete disclosed trade history on the member profile. Thomas MacArthur's trade history

Is congressional stock trading legal?

The STOCK Act does not impose a blanket ban on members holding or trading individual securities. It requires public disclosure of covered transactions, generally within 30 days of receiving notice and no later than 45 days after the transaction. Other laws and chamber rules may also apply. STOCK Act

Is Congress exempt from insider trading laws?

No. The STOCK Act expressly affirms that members and congressional employees are not exempt from federal insider-trading prohibitions and owe a duty arising from their positions. Public disclosure is a separate obligation and does not shield a trade from those laws. STOCK Act

How quickly must members of Congress disclose a trade?

Under the STOCK Act, a covered transaction generally must be reported on a Periodic Transaction Report within 30 days of receiving notice and no later than 45 days after the transaction. House Ethics guidance describes the reporting schedule and applicable late-filing fee. House Ethics PTR guidance

How is net worth reported in these disclosures?

It is not. STOCK Act filings report transaction and asset ranges, not a complete or real-time net worth. Quantellect does not estimate a member's net worth from these filings; any third-party estimate is not part of the official disclosure. STOCK Act

Like this article? Share it
Methodology & disclaimer. Trades reflect Periodic Transaction Reports filed under the STOCK Act of 2012, which requires members of Congress to disclose covered transactions, generally within 30 days of receiving notice of the transaction and no later than 45 days after the transaction; disclosed amounts are the broad ranges in the official filing, not exact figures. Estimated prices and post-trade returns are derived from end-of-day market data and may be revised as filings are amended. The Member Score measures a member's disclosed-trade track record against a sector-matched benchmark. This article is generated programmatically for education and research only. It is not investment advice, a recommendation, or an allegation of unlawful trading.

Trades reflect disclosures filed under the STOCK Act and are provided for informational purposes only, not investment advice. Amounts are ranges from official filings; estimated prices and post-trade returns are derived from end-of-day market data and may be revised as filings are amended.